CD44 and cancer: Hyaluronic acid (HA) is a popular molecule for tailoring nanocarriers to target CD44, a transmembrane glycoprotein overexpressed in cancers, with implications in tumor cell proliferation, differentiation, motility, and chemoresistance [75,115].